01/ 04
Connect evidence
Align sequence or construct context with synthesis records and reagent lots.
01
← All modalities
ASO · SIRNA
RNA and oligonucleotides
Connect synthesis-stage records, reagents, processing, purification and analytical measurements. Preserve sequence or construct context so teams can compare yield, purity and impurity profiles across the complete workflow.
ASO · siRNARNA and oligonucleotides
OUTCOMES TRACKEDYieldpurityimpurity profile
MODALITY-SPECIFIC PROCESS INTELLIGENCE
Trace synthesis and purification into final quality.
01Synthesis
02Cleavage / processing
03Purification
04Analytical quality
FOCUS AREA · Synthesis
Synthesis context
Review cycle or synthesis conditions, reagent lots and stage-level efficiency measurements.
01
EVIDENCE · MODELS · DECISIONS
Keep every conclusion connected.
Evidence in Bio Hub
- Synthesis cycles, reagents and material lots
- Coupling efficiency and purification records
- Identity, purity and impurity measurements
Models in Bio Twin
- Reaction efficiency and loss analysis
- Purification and impurity comparisons
- Yield and process sensitivity
Scientific decisions
- Investigate step-dependent yield losses
- Compare purification conditions
- Connect synthesis changes to analytical quality
Process outcomes to evaluate: Yield · purity · impurity profile
EXAMPLE INVESTIGATION
At which stage did the yield or impurity profile change?
02/ 04
Compare context
Compare stage-level efficiency and processing observations across the selected runs.
02
03/ 04
Evaluate explanations
Trace purification recovery to identity, purity and impurity assay results.
03
04/ 04
Review next steps
Prepare a stage-specific investigation and prioritize the next experiment or analytical measurement.
04
Bio Agents can coordinate the scientific work across evidence and models, while Bio OS preserves governance and human review. The configured workflow determines which tasks and models are available.
Bring us this process challenge ↗EVALUATION & SCOPE
Make the demonstration specific.
Agree on the exact synthesis chemistry, construct, purification stages and analytical methods. ASO, siRNA and other RNA workflows may require different models and process configurations.
What evidence should we bring?
Synthesis cycles, reagents and material lots. Coupling efficiency and purification records. Identity, purity and impurity measurements. Include the process question, relevant run context and the analytical methods used to assess the outcome.
How do models support the workflow?
Reaction efficiency and loss analysis. Purification and impurity comparisons. Yield and process sensitivity. Scope and evaluation criteria are defined for your process, data and intended decision.
What should we validate before using the results?
Agree on the exact synthesis chemistry, construct, purification stages and analytical methods. ASO, siRNA and other RNA workflows may require different models and process configurations.
EXPLORE OTHER MODALITIES
ENTERPRISE USE CASE
Balancing oligonucleotide purity and recovery across synthesis campaigns
A synthetic ASO-focused use case connecting sequence/process context, impurity characterization and purification pooling.
Explore the complete use case ↗